About Sukumar Nagendran
Sukumar Nagendran is a director at Amlogenyx.
Sukumar Nagendran reports to the SEC as a director or officer of 4 public companies, including Taysha Gene Therapies (TSHA), Solid Biosciences (SLDB) and Immunovant (IMVT).
Sukumar Nagendran first appears on SEC filings in 2016.
Experience
This experience comes from Sukumar Nagendran's profile and from SEC filings. For roles taken from filings, the years are when the filings name Sukumar Nagendran in the role, so the role may have started earlier or lasted longer.
Amlogenyx Inc. Current
Director
2025 – Present · Novato, CA
Develops an investigational gene therapy for people with Alzheimer's disease.
TI
Taysha Gene Therapies, Inc. Current
President and Head of R&D, director
2020 – Present · Public company (TSHA)
SA
Saliogen Current
Board Member
2020 – Present
PM
Project Healthy Minds Current
Independent Director
2020 – Present
MI
Medocity, Inc. Current
Board Member
2019 – Present
RS
RTW Investments SPAC Current
Member Board Of Directors
2019 – Present
SI
Solid Biosciences Inc. Current
Member Board Of Directors
2018 – Present · Public company (SLDB)
CH
Chardan Current
Special Advisor
2018 – Present
ET
Encoded Therapeutics Current
Advisor
2018 – Present
JT
Jaguar Gene Therapy
President, R&D and Chief Medical Officer
2020 – 2023
NI
Neurogene, Inc.
Member Board Of Directors
2019 – 2021
II
Immunovant, Inc.
Director
2019 · Public company (IMVT)
AI
AveXis, Inc.
Sr. VP & Chief Medical Officer
Sr VP & Chief Medical Officer (2015 – 2018)
2015 – 2018 · Public company (AVXS)
QD
Quest Diagnostics
VP- Head Of Medical Affairs; US and International Business
2013 – 2015
RP
Reata Pharmaceuticals
VP, Head Of Medical Affairs
2012 – 2013
DS
Daiichi Sankyo
Executive Medical Director ( Medical Affairs)- Multi Therapeutic Areas and Clinical Operations
2008 – 2012
NO
Novartis
Lead for CVM Med Affairs/Med Director
2007 – 2008
PF
Pfizer
Director/Team Leader- US Diabetes and Metabolism
2001 – 2007
DM
Diabetes and Internal Medicine
Consultant Physician
1997 – 2000
Key Colleagues at Startups
The people Sukumar Nagendran works with at each company, as listed on that company's latest Form D.
Amlogenyx Inc. · Form D, Jul 9, 2026
John Pinion
Chief Operations Officer
Craig Gordon
Director
Emil Kakkis
Founder and Chairman
TH
Ted Huizenga
Executive officer
KP
Karah Parschauer
Executive officer